BioMed and Collaborator Chemveda Life Sciences Enter Agreement for Synthesis and Manufacturing of Liver Cancer Chemotherapeutic.

Chemveda Life Sciences and Q BioMed, Inc. Announce Potential Chemotherapeutic Breakthrough in Liver Cancer

Professor K.C. Nicolaou visits Chemveda Life Sciences

Dr. Bheema Paraselli, CEO, Chemveda Life Sciences attends the OMRF BioVenture Forum